Çocuklarda Uyku Bozukluklarının Tanı ve Tedavisi

Authors

Ebru Arhan

References

Okawa M, Sasaki H. Sleep disorders in mentally retarded and brain-impaired children. In: Sleep and its Disorders in Children, Guilleminault C (Ed), Raven Press, New York 1987. p.269.
Dillon JE and Chervin RD. Attention deficit, hyperactivity, and sleep disorders. In: Principles and Practice of Pediatric Sleep Medicine, 2 Ed, Sheldon SH, Ferber R, Kryger MH, and Gozal D (Eds), Elsevier Saunders, New York 2014. p.111.
Gringras P. Sleep and its disturbances in autism spectrum disorder. In: Principles and Practice of Pediatric Sleep Medicine, 2 Ed, Sheldon SH, Ferber R, Kryger MH, and Gozal D (Eds), Elsevier Saunders, New York 2014. p.125.
Paruthi S, Brooks LJ, D'Ambrosio C, et al. Recommended Amount of Sleep for Pediatric Populations: A Consensus Statement of the American Academy of Sleep Medicine. J Clin Sleep Med 2016; 12:785.
Recommended Amount of Sleep for Pediatric Populations. Pediatrics 2016; 138.
World Health Organization. Guidelines on physical activity, sedentary behaviour and sleep for children under 5 years of age. 2019. Available at: http://www.who.int/iris/handle/10665/311664 (Accessed on May 03, 2019).
American Academy of Sleep Medicine: Bedtime calculator. Available at: https://sleepeducation.org/healthy-sleep/bedtime-calculator/ (Accessed on October 08, 2021).
Owens JA, Dalzell V. Use of the 'BEARS' sleep screening tool in a pediatric residents' continuity clinic: a pilot study. Sleep Med 2005; 6:63.
Principles and Practice of Pediatric Sleep Medicine, 2 Ed, Sheldon SH, Ferber R, Kryger MH, Gozal D (Eds), Elsevier Saunders, New York 2014.
Chervin RD, Dillon JE, Bassetti C, et al. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep 1997; 20:1185.
Owens J, Opipari L, Nobile C, Spirito A. Sleep and daytime behavior in children with obstructive sleep apnea and behavioral sleep disorders. Pediatrics 1998; 102:1178.
Grigg-Damberger M, Ralls F. Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders. Curr Opin Pulm Med 2013; 19:616.
Ortho-McNeal Pharmaceuticals. Topiramate package insert.
Owens JA. Pharmacology of sleep. In: Principles and Practice of Pediatric Sleep Medicine, 2 Ed, Sheldon SH, Ferber R, Kryger MH, and Gozal D (Eds), Elsevier Saunders, New York 2014. p.53.
Aurora RN, Lamm CI, Zak RS, et al. Practice parameters for the non-respiratory indications for polysomnography and multiple sleep latency testing for children. Sleep 2012; 35:1467.
Aurora RN, Zak RS, Karippot A, et al. Practice parameters for the respiratory indications for polysomnography in children. Sleep 2011; 34:379.
Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005; 28:499.
Berry RB, Quan SF, Abreu AR, et al for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.6, www.aasmnet.org, American Academy of Sleep Medicine, Darien, IL 2020
Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28:113.
American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, American Academy of Sleep Medicine, 2014.
Hoban TF, Chervin RD. Assessment of sleepiness in children. Semin Pediatr Neurol 2001; 8:216.
Ancoli-Israel S, Martin JL, Blackwell T, et al. The SBSM Guide to Actigraphy Monitoring: Clinical and Research Applications. Behav Sleep Med 2015; 13 Suppl 1:S4.
Mindell JA, Emslie G, Blumer J, et al. Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics. 2006;117(6):e1223–1232.
Owens JA, Babcock D, Blumer J, et al. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. a consensus meeting summary. J Clin Sleep Med. 2005;1(1):49–59.
Owens JA, Moturi S. Pharmacologic treatment of pediatric insomnia. Child Adolesc Psychiatr Clin N Am. 2009;18(4):1001–1016.
Ivanenko A, Crabtree VM, Obrien LM, et al. Sleep complaints and psychiatric symptoms in children evaluated at a pediatric mental health clinic. J Clin Sleep Med. 2006;2(1):42–48
Waldron AY, Spark MJ, Dennis CM. The use of melatonin by children: parents’ perspectives. J Clin Sleep Med 2016;12:1395-401.
Bruni O, Alonso-Alconada D, Besag F, Biran V, Braam W, Cortese S, et al. Current role of melatonin in pediatric neurology: clinical recommendations. Eur J Paediatr Neurol 2015;19:122-33.
Skrzelowski M, Brookhaus A, Shea LA, Berlau DJ. Melatonin Use in pediatrics: evaluating the discrepancy in evidence based on country and regulations regarding production. J Pediatr Pharmacol Ther 2021;26:4-20.
Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL. Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2017;56:948-57.e4.
Schenck CH, Mahowald MW. Parasomnias associated with sleepdisordered breathing and its therapy, including sexsomnia as a recently recognized parasomnia. Somnologie. 2008;12(1):38–49.
Nielsen T, Levin R. Nightmares: a new neurocognitive model. Sleep Med Rev. 2007;11(4):295–310
Benign sleep myoclonus of infancy. In: The International Classification of Sleep Disorders: Diagnostic and Coding Manual, Second Edition. Westchester, IL: American Academy of Sleep Medicine; 2005:211–212.
Simakajornboon N, Gozal D, Vlasic V, et al. Periodic limb movements in sleep and iron status in children. Sleep. 2003;26(6):735–738
Wagner ML, Walters AS, Coleman RG, et al. A randomized doubleblind placebo controlled study of clonidine in restless legs syndrome. Sleep. 1996;19:52–58
Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, crossover study. Neurology. 2002;59:1573–1579.
Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc. 2004;79:916–922
Konofal E, Arnulf I, Lecendreux M, et al. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol. 2005;32:350–351. 50.
Walters AS, Mandelbaum DE, Lewin DS, et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatr Neurol.2000;22:182–186
Nofzinger EA, Fasiczka A, Berman S, et al. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry. 2000;61:858–862.
Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry. 2005;58:510–514.
Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005;1;28(7):891–898.
Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, et al. Narcolepsy—clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39.
Franceschini C, Pizza F, Antelmi E, Folli MC, Plazzi G. Narcolepsy treatment: pharmacological and behavioral strategies in adults and children. Sleep Breath 2019;24:615-27.
Kotagal S. Treatment of narcolepsy and other organic hypersomnias in children. Paediatr Respir Rev 2018;25:19-24.
Lecendreux M, Plazzi G, Franco P, Jacqz-Aigrain E, Robert P, Duvauchelle T, et al. Pharmacokinetics of pitolisant in children and adolescents with narcolepsy. Sleep Med 2020;66:220-6
Filardi M, Pizza F, Antelmi E, Ferri R, Natale V, Plazzi G. In-field assessment of sodium oxybate effect in pediatric type 1 narcolepsy: an actigraphic study. Sleep 2018;41
Carberry JC, Amatoury J, Eckert DJ. Personalized management approach for OSA. Chest 2018;153:744-55.
Siriwardhana LS, Nixon GM, Horne RSC, Edwards BA. Journey towards a personalised medicine approach for OSA: can a similar approach to adult OSA be applied to paediatric OSA? Paediatr Respir Rev 2020;36: 128-35.
Siriwardhana LS, Weichard A, Nixon GM, Davey MJ, Walter LM, Edwards BA, et al. Role of ventilatory control instability in children with sleep-disordered breathing. Respirology 2020;25:1174-82.
Chan CC, Au CT, Lam HS, Lee DL, Wing YK, Li AM. Intranasal corticosteroids for mild childhood obstructive sleep apnea–a randomized, placebo-controlled study. Sleep Med 2015;16:358-63.
Kheirandish-Gozal L, Bandla HP, Gozal D. Montelukast for Children with obstructive sleep apnea: results of a double-blind, randomized, placebo-controlled trial. Ann Am Thorac Soc 2016;13:1736-41
Liming BJ, Ryan M, Mack D, Ahmad I, Camacho M. Montelukast and nasal corticosteroids to treat pediatric obstructive sleep apnea: a systematic review and meta-analysis. Otolaryngology Head Neck Surg 2019;160: 594-602.
Taranto-Montemurro L, Messineo L, Sands SA, Azarbarzin A, Marques M, Edwards BA, et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. a randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med 2019;199:1267-76.
Castro-Codesal ML, Dehaan K, Bedi PK, Bendiak GN, Schmalz L, Katz SL, et al. Longitudinal changes in clinical characteristics and outcomes for children using long-term non-invasive ventilation. PloS One 2018;13:e0192111.
Bhattacharjee R, Benjafield AV, Armitstead J, Cistulli PA, Nunez CM, Pepin J-LD, et al. Adherence in children using positive airway pressure therapy: a big-data analysis. Lancet Digital Health 2020;2:e94-101.
Hawkins S, Huston S, Campbell K, Halbower A. High-flow, heated, humidified air via nasal cannula treats CPAP-intolerant children with obstructive sleep apnea. J Clin Sleep Medicine JCSM 2017;13:981-9.
Amaddeo A, Khirani S, Frapin A, Teng T, Griffon L, Fauroux B. Highflow nasal cannula for children not compliant with continuous positive airway pressure. Sleep Med 2019;63:24-8.
Camacho M, Chang ET, Song SA, Abdullatif J, Zaghi S, Pirelli P, et al. Rapid maxillary expansion for pediatric obstructive sleep apnea: a systematic review and meta-analysis. Laryngoscope 2017;127:1712-9
Villa MP, Brasili L, Ferretti A, Vitelli O, Rabasco J, Mazzotta AR, et al. Oropharyngeal exercises to reduce symptoms of OSA after AT. Sleep Breath 2015;19:281-9.
Wilcox LJ, Bergeron M, Reghunathan S, Ishman SL. An updated reviewof pediatric drug-induced sleep endoscopy. Laryngoscope Invest Otolaryngol 2017;2:423-31.
Strollo PJ Jr, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 2014;370:139-49.
Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014;149:275-87.
DelRosso LM, Bruni O, Ferri R. Restless sleep disorder in children: a pilot study on a tentative new diagnostic category. Sleep 2018;41:zsy102.
DelRosso LM, Jackson CV, Trotter K, Bruni O, Ferri R. Video-polysomnographic characterization of sleep movements in children with restless sleep disorder. Sleep 2019;42:zsy269.

Published

March 18, 2023

License

License

How to Cite

1.
Arhan E. Çocuklarda Uyku Bozukluklarının Tanı ve Tedavisi. In: Canpolat M, Per H, Gümüş H, editors. Çocuklarda Uyku Bozuklukları [Internet]. Türkiye: Academician Publishing Book DOI Portal; 2023 [cited 2026 Jul. 16]. pp. 91-114. Available from: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/2512/chapter/13074